ProfileGDS4718 / 1569849_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 37% 37% 39% 40% 37% 35% 32% 37% 43% 36% 38% 38% 40% 36% 36% 37% 39% 36% 41% 38% 34% 40% 40% 43% 40% 35% 39% 41% 37% 38% 38% 35% 40% 42% 39% 38% 37% 33% 40% 32% 34% 39% 38% 39% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8469337
GSM549102patient 115, normal, homogenized [OPG study]4.8905937
GSM549104patient 119, normal, homogenized [OPG study]4.9249739
GSM549108patient 138, normal, homogenized [OPG study]5.0516840
GSM549119patient 077, normal, homogenized [OPG study]4.8622837
GSM549133patient 032, cancer, homogenized [OPG study]4.6851735
GSM549139patient 042, cancer, homogenized [OPG study]4.5904732
GSM549099patient 107, normal, homogenized [OPG study]4.8572537
GSM549109patient 139, normal, homogenized [OPG study]5.1402243
GSM549110patient 046, normal, homogenized [OPG study]4.8069536
GSM549114patient 063, normal, homogenized [OPG study]4.8521138
GSM549122patient 082, normal, homogenized [OPG study]4.885938
GSM549134patient 033, cancer, homogenized [OPG study]4.9826240
GSM549136patient 036, cancer, homogenized [OPG study]4.7263836
GSM549140patient 044, cancer, homogenized [OPG study]4.7391936
GSM549111patient 047, normal, homogenized [OPG study]4.8296437
GSM549113patient 057, normal, homogenized [OPG study]4.8851539
GSM549132patient 031, cancer, homogenized [OPG study]4.8054136
GSM549137patient 038, cancer, homogenized [OPG study]5.0220841
GSM549142patient 047, cancer, homogenized [OPG study]5.0133538
GSM549100patient 110, normal, homogenized [OPG study]4.7181534
GSM549107patient 135, normal, homogenized [OPG study]4.9464440
GSM549115patient 068, normal, homogenized [OPG study]4.928240
GSM549116patient 072, normal, homogenized [OPG study]5.1262143
GSM549120patient 078, normal, homogenized [OPG study]5.0007840
GSM549131patient 030, cancer, homogenized [OPG study]4.690735
GSM549118patient 074, normal, homogenized [OPG study]4.9303339
GSM549129patient 027, cancer, homogenized [OPG study]5.0367741
GSM549123patient 088, normal, homogenized [OPG study]4.8274737
GSM549124patient 006, cancer, homogenized [OPG study]4.9455738
GSM549126patient 015, cancer, homogenized [OPG study]4.8729138
GSM549128patient 025, cancer, homogenized [OPG study]4.7299735
GSM549103patient 117, normal, homogenized [OPG study]5.0751540
GSM549117patient 073, normal, homogenized [OPG study]5.0652542
GSM549138patient 041, cancer, homogenized [OPG study]4.9208839
GSM549141patient 045, cancer, homogenized [OPG study]4.8398538
GSM549130patient 028, cancer, homogenized [OPG study]4.8486337
GSM549101patient 111, normal, homogenized [OPG study]4.6831233
GSM549105patient 128, normal, homogenized [OPG study]4.9965540
GSM549106patient 134, normal, homogenized [OPG study]4.5864632
GSM549112patient 048, normal, homogenized [OPG study]4.7258134
GSM549125patient 011, cancer, homogenized [OPG study]4.9347339
GSM549127patient 024, cancer, homogenized [OPG study]4.8712538
GSM549135patient 035, cancer, homogenized [OPG study]4.9073539